The following deals were announced Thursday, April 28, 2016.*
Acquirer | Acquiree | Offer Amount | Specialty | |
|---|---|---|---|---|
| 1 | Sanofi | Medivation | $9.3 billion (rejected) | Oncology |
| 2 | Abbott Laboratories | St. Jude Medical | $25 billion | Cardiovascular devices |
| 3 | AbbVie | Stemcentrx | $5.8 billion | Oncology |
